These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Asthma in adults. Dennis RJ, Solarte I, Fitzgerald JM. BMJ Clin Evid; 2007 Aug 15; 2007():. PubMed ID: 19454105 [Abstract] [Full Text] [Related]
25. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma. Currie GP, Lee DK, Menzies D, Lipworth BJ. Chest; 2006 Jul 15; 130(1):301-2. PubMed ID: 16840420 [No Abstract] [Full Text] [Related]
26. Leukotriene receptor antagonists as add-on therapy for adults with asthma. Thomson NC, Shepherd M. Thorax; 2003 Mar 15; 58(3):190-2. PubMed ID: 12612289 [Abstract] [Full Text] [Related]
27. Inhaled corticosteroid use and asthma hospitalization rates in Japan. Odajima Y, Kuwabara H. J Int Med Res; 2006 Mar 15; 34(2):208-14. PubMed ID: 16749417 [Abstract] [Full Text] [Related]
28. Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications. Herborg H, Soendergaard B, Jorgensen T, Fonnesbaek L, Hepler CD, Holst H, Froekjaer B. J Am Pharm Assoc (Wash); 2001 Mar 15; 41(4):551-9. PubMed ID: 11486981 [Abstract] [Full Text] [Related]
33. New combination therapies for asthma. Donohue JF, Ohar JA. Curr Opin Pulm Med; 2001 Mar 15; 7(2):62-8. PubMed ID: 11224725 [Abstract] [Full Text] [Related]
34. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids. Nelson HS, Nathan RA, Kalberg C, Yancey SW, Rickard KA. MedGenMed; 2001 Jul 05; 3(4):3. PubMed ID: 11549982 [Abstract] [Full Text] [Related]
35. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children. Blais L, Kettani FZ, Lemière C, Beauchesne MF, Perreault S, Elftouh N, Ducharme FM. Respir Med; 2011 Jun 05; 105(6):846-55. PubMed ID: 21196105 [Abstract] [Full Text] [Related]
36. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review. Colucci R, Fornai M, Tuccori M, Antonioli L, Pasqualetti G, Blandizzi C, Del Tacca M. J Asthma; 2007 Jun 05; 44(6):411-22. PubMed ID: 17654125 [Abstract] [Full Text] [Related]
37. Combination therapy of bronchial asthma. Nelson HS. Allergy Asthma Proc; 2001 Jun 05; 22(4):217-20. PubMed ID: 11552671 [Abstract] [Full Text] [Related]
38. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cates CJ, Lasserson TJ, Jaeschke R. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD006924. PubMed ID: 19370661 [Abstract] [Full Text] [Related]
39. Leukotriene receptor antagonists in the treatment of asthma: an update. Balzano G, Fuschillo S, Gaudiosi C. Allergy; 2002 Apr 15; 57 Suppl 72():16-9. PubMed ID: 12144548 [Abstract] [Full Text] [Related]
40. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis. Sobieraj DM, Baker WL, Nguyen E, Weeda ER, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE. JAMA; 2018 Apr 10; 319(14):1473-1484. PubMed ID: 29554174 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]